-
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome
van den Broek, W. W. A., Azzahhafi, J., Yin, D. R. P. P. C. P., van der Sangen, N. M. R., Sivanesan, S., Dijksman, L. M., Walhout, R. J., Tjon Joe Gin, M., Breet, N. J., Langerveld, J., Vlachojannis, G. J., van Bommel, R. J., Appelman, Y., van Schaik, R. H. N., Henriques, J. P. S., Kikkert, W. J. & ten Berg, J. M., 1 May 2025, In: European Heart Journal - Cardiovascular Pharmacotherapy. 11, 3, p. 230-240 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients
Azzahhafi, J., van den Broek, W. W. A., Chan Pin Yin, D. R. P. P., van der Sangen, N. M. R., Sivanesan, S., Bofarid, S., Peper, J., Claassens, D. M. F., Janssen, P. W. A., Harmsze, A. M., Walhout, R. J., Tjon Joe Gin, M., Nicastia, D. M., Langerveld, J., Vlachojannis, G. J., van Bommel, R. J., Appelman, Y., van Schaik, R. H. N., Henriques, J. P. S. & Kikkert, W. J. & 1 others, , 9 Sept 2024, In: JACC: Cardiovascular Interventions. 17, 17, p. 1996-2007 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A paradigm shift in antithrombotic therapy
van der Sangen, N. M. R., 2024, 253 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
- All publications
